- Lapatinib plus capecitabine compared to capecitabine alone in patients with metastatic HER2-positive breast cancer-evaluation of the quality of life2009 | First Faculty of Medicine
- Capecitabin in chemotherapy - mohr than new way administer fluoropyrimids2007 | Faculty of Physical Education and Sport
- Capecitabin in chemotherapy - mohr than new way administer fluoropyrimids2007 | First Faculty of Medicine
- Research Report University Hospital for clinical assessment PUMA-NER-1301Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no.MO22324Publication without faculty affiliation
- Final report of University Hospital Hradec Kralove to the clinical trial protocol no. I4T-MC-JVCUPublication without faculty affiliation
- Capecitabine in the treatment of anal squamous cell carcinoma2022 | First Faculty of Medicine
- Capecitabin e and oxaliplatin (XELOX) in adjuvant therapy of colorectal cancer. Results of the NO16968 (XELOXA) trial2010 | First Faculty of Medicine
- Different expression of thymidinphosphorylase in bowel mucosa and in primary colorectal tumor. The rationale principle for selective activation of capecitabine.2005 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Central Library of Charles University
- First-line trastuzumab (H), oral vinorelbine (NVBo) and capecitabine (X) combination therapy for HER2-positive metastatic breast cancer (MBC): efficacy and safety in a multinational phase 2 studyPublication without faculty affiliation
- Bevacizumab with 5-fluorouracil, leucovorin, and oxaliplatin versus bevacizumab with capecitabine and oxaliplatin for metastatic colorectal carcinoma: results of a large registry-based cohort analysis2014 | First Faculty of Medicine
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | First Faculty of Medicine, Faculty of Medicine in Pilsen
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | Central Library of Charles University
- A Phase II Trial of Oral Vinorelbine and Capecitabine in Anthracycline Pretreated Patients with Metastatic Breast Cancer2009 | First Faculty of Medicine
- Different expression of thymidinphosphorylase in bowel mucosa and in primary colorectal tumor. The rationale principle for selective activation of capecitabine.2005 | Central Library of Charles University, Faculty of Medicine in Pilsen
- Chemoradiotherapy - mechanism of increased cytostatics activation during the post-radiation reaction2005 | Third Faculty of Medicine
- Phase II Study of a Triple Combination of Oral Vinorelbine, Capecitabine and Trastuzumab as First-line Treatment in HER2-positive Metastatic Breast Cancer2013 | First Faculty of Medicine
- Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis2014 | First Faculty of Medicine
- Chemotherapy - mechanism of enhanced activation of cytostatics within a post-radiation reaction2005 | First Faculty of Medicine
- High efficacy of the combination chemotherapy (CT) of oral vinorelbine (NVBO) and capecitabine (X) with trastuzumab (H) in HER2-positive metastatic breast cancer (MBC): updated analysis of the results of an international phase 2 trialPublication without faculty affiliation
- A phase II trial of oral vinorelbine and capecitabine in anthracycline pretreated patients with metastatic breast cancer2009 | Faculty of Medicine in Pilsen
- Research Report University Hospital for clinical assessment 20070622Publication without faculty affiliation
- Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial2016 | First Faculty of Medicine
- The current view of the pharmacotherapy of inoperable metastatic colorectal cancer2015 | First Faculty of Medicine
- MicroRNA expression profile associated with response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients2012 | Faculty of Medicine in Hradec Králové
- Local Treatment of Hand-Foot Syndrome with Uridine/Thymidine: In Vitro Appraisal on a Human Keratinocyte Cell Line HaCaT2012 | First Faculty of Medicine, Third Faculty of Medicine
- Clinical relevance of DPYD variants c.1679T>G, c.1236G>A/HapB3, and c.1601G>A as predictors of severe fluoropyrimidine-associated toxicity: a systematic review and meta-analysis of individual patient data2015 | First Faculty of Medicine
- Predictive and prognostic factors of gastric cancer2016 | Faculty of Medicine in Pilsen
- Pharmacotherapy of colon cancer, rectosigmoid junction and rectum2011 | Publication without faculty affiliation